Company Filing History:
Years Active: 2015-2018
Title: Kathleen McCaffrey: Pioneer in Hepatitis C Research
Introduction
Kathleen McCaffrey is an accomplished inventor based in Singapore, SG, known for her significant contributions to the field of medical research, particularly in relation to the hepatitis C virus (HCV). She holds two patents that demonstrate her innovative approach to understanding and combating this challenging viral infection.
Latest Patents
McCaffrey's latest patents reflect her ingenuity and dedication to advancing HCV research. The first patent involves "Compositions and Methods," which provides a groundbreaking composition comprising hepatitis C virus Envelope 2 (E2) glycoprotein. This innovation features substantially monomer-depleted HCV E2 and includes methods for inducing an HCV immune response. The second patent focuses on "Modified Hepatitis C Virus Proteins." It describes a composition comprising an HCV E2 polypeptide that includes a receptor binding variant, engineered to minimize multimers formed by intermolecular disulfide bonding while retaining the ability to bind CD81 effectively. Her method emphasizes producing a high percentage of monomelic HCV E2 polypeptide by expressing and isolating the modified polypeptide within a host cell.
Career Highlights
Kathleen McCaffrey's work is primarily conducted at the Macfarlane Burnet Institute for Medical Research and Public Health Limited, where she collaborates with fellow researchers to drive innovative solutions to complex health challenges. McCaffrey's dedication to research has positioned her as a notable figure in the field of infectious diseases.
Collaborations
Throughout her career, McCaffrey has worked alongside esteemed colleagues, including Heidi Drummer and Pantelis Poumbourios. Their collaborative efforts have furthered the understanding of hepatitis C and contributed to the development of potential therapeutic strategies.
Conclusion
Kathleen McCaffrey exemplifies how innovation in research can lead to significant advancements in medicine. With her two patents in the field of hepatitis C, she continues to impact the healthcare landscape positively. Her contributions through collaboration and invention hold promise for future discoveries and developments, ultimately working towards better therapeutic outcomes for those affected by hepatitis C.